New cocktail of drugs takes on tough pancreatic cancer
NCT ID NCT06076837
First seen Jan 12, 2026 · Last updated May 13, 2026 · Updated 17 times
Summary
This early-phase trial tests whether adding two immune-boosting drugs (botensilimab and balstilimab) to a strong chemotherapy mix plus two oral medications can help people with untreated metastatic pancreatic cancer. The study involves 6 participants and aims to find the safest dose and check for side effects. It is not a cure, but a step toward better control of this aggressive cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER METASTATIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Trials Nurse Navigator
Scottsdale, Arizona, 85258, United States
Conditions
Explore the condition pages connected to this study.